Other Private Equity/Strategic Investments
Sun Pharma acquires 27% stake in eye care devices co Remidio for Rs.150-Cr
Publicly listed, Mumbai-based pharmaceutical company Sun Pharma has acquired 27.39% of Bengaluru-based Remidio Innovative Solutions Pvt Ltd, which provides products enabling the early detection of eye diseases, for INR 149.9 crore in cash. Remidio's revenue from operations for the year 2021-22 on a consolidated basis was INR 26.61 crore. The company, incorporated in 2019, has a subsidiary ‘Remidio Innovation Solutions Inc' in the US and ‘Medios Technologies Pte Ltd' in Singapore.
From the Venture Intelligence PE-VC Deal Database: Between Aug-17 and Dc-19, Remidio had raised over USD 4 M from KITVEN, Montane Ventures, others. (Subscribers to the database can login to view the valuation, deal structuring and other transaction details.)
Want to receive such news items in your inbox? Click Here to sign up for a trial.
